Navigation Links
Gasification method turns forest residues to biofuel with less than a euro per liter
Date:7/3/2013

According to the new research results of the VTT Technical Research Centre of Finland, lignocellulosic biomass can be used in the production of high-quality biofuels for the price of less than one euro per litre. A new technology developed in Finland allows the transfer of more than half the energy of wood raw materials to the end-product. The technology is considered ready for the construction of a commercial-scale production plant in Europe.

VTT has assessed the techno-economics of the production of renewable liquid transportation fuels from forest residues. The case studies focused on the production of four biofuels using a method based on pressurised fluidised-bed gasification. The fuels studied were methanol, dimethyl ether (DME), Fischer-Tropsch liquids and synthetic gasoline.

The results show that the production of renewable biofuels from lignocellulosic biomass, mainly bark and forestry residues, could achieve an energy efficiency of 50%, depending on the end-product and process conditions. Should the thermal energy produced as a by-product be exploited for district heat or industrial steam, for example, the overall efficiency from biomass to saleable energy products could reach 74%.

Based on the case studies, the research scientists estimated that once commercialised the technology can be used to produce liquid transportation fuel at the cost of 58 /MWh. Converted into gasoline-equivalent price per litre, the estimated production cost would be 0.5.7 /litre. The price of renewable solutions would thus be on a level with the current pre-tax price of fossil transportation fuels, and cheaper than existing imported biofuels.

Each case study design was based on a BTL plant with 300 MW capacity, the equivalent of a large district heating power plant. A biorefinery of this size could produce liquid transportation fuel for about 150 000 cars. The EU has set a target of 10% renewable energy content for the transportation sector by 2020. For Finland, the target is 20%.

After long-term development work, the technical functionality of the production process was verified through extensive testing at VTT test rigs as well as industrial piloting in Finland and in the US. The technology is now ready for its first commercial-scale demonstration. However, the first wave of these ground-breaking production plants requires significant public venture capital investment, for which planning has consequently been initiated at both Finnish and EU level.

According to the research results, the best efficiency and lowest production costs were achieved in the production of biomethanol. The risks related to the commercialisation of the synthesis technology were also estimated to be lower with the biomethanol production plant compared to the other options.

Methanol is an alcohol fuel that can be used in modern cars at maximum 3 vol-% content in combination with petrol or, as with ethanol, in high concentrations in FlexFuel cars designed for this purpose. Methanol can also be further converted to synthetic gasoline or used as renewable raw material in the manufacture of various chemicals and biomaterials.


'/>"/>

Contact: Esa Kurkela
esa.kurkela@vtt.fi
358-207-225-596
VTT Technical Research Centre of Finland
Source:Eurekalert

Related biology news :

1. Gasification method turns forest residues to biofuel with less than a euro per litre
2. Bioliq pilot plant: Successful operation of high-pressure entrained flow gasification
3. Too green to be true? Researchers develop highly effective method for converting CO2 into methanol
4. Testing method promising for spinal cord injuries, multiple sclerosis
5. Researchers develop a faster method to identify Salmonella strains
6. Research examines new methods for managing digestive health
7. New X-ray method shows how frog embryos could help thwart disease
8. Researchers reveal new more precise method of performing electroconvulsive therapy
9. Resistant starch content of potatoes varies significantly by preparation and service method
10. New research projects to enhance bioinformatics and computational biology tools and methodologies
11. Material screening method allows more precise control over stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2016)... York , June 15, 2016 ... new market report titled "Gesture Recognition Market by Application ... Forecast, 2016 - 2024". According to the report, the  ... 11.60 billion in 2015 and is estimated to ... USD 48.56 billion by 2024.  Increasing ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ... congratulate long-term client Nanowear on their recent FDA Class II 510(k) clearance for ... a significant hurdle in commercializing remote cardiac monitoring devices that rely on cloth-based ...
(Date:12/2/2016)...   SurePure, Inc. (OTCQB: SURP) a global ... has concluded an agreement with Tamarack Biotics under which ... to acquire units of the Company,s patented photopurification technology ... Concurrently with the option, SurePure has ... will seek regulatory approvals in the United ...
(Date:11/30/2016)... ... November 30, 2016 , ... BEI ... Coil Actuator with a flexure design that ensures high alignment accuracy by preventing ... and is ideally suited where extreme precision is required, such as in medical ...
(Date:11/30/2016)... 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... excited to announce the formation of EyGen, Ltd. ... ophthalmology assets through proof of concept. EyGen,s lead ... Portage Pharmaceuticals Limited and being developed for topical ... anterior segment diseases. This agent has the potential ...
Breaking Biology Technology: